Literature DB >> 2451485

The effects of Hespan on serum and lymphatic albumin, globulin, and coagulant protein.

C E Lucas1, R Denis, A M Ledgerwood, D Grabow.   

Abstract

The effects of hydroxyethyl starch (Hespan) resuscitation on serum and lymphatic proteins following hemorrhagic shock were studied in 34 splenectomized dogs. Following shock, five randomly assigned treatment groups received the shed blood plus 50 mL/kg of salt solution (RL) or RL with varying concentrations (0.22-1.5 gm/kg) of Hespan. Each dog received 50 ml/kg/d of the test solution for three days after shock. Prothrombin time, partial thromboplastin time, thrombin time, total serum protein, albumin, globulin, and coagulant protein activity of fibrinogen, prothrombin, and factor VIII were measured before shock, at the end of shock, following resuscitation, and on day 3; thoracic duct lymph values were obtained on day 3. Hespan-supplemented resuscitation lowered all serum proteins including albumin, globulin and coagulant proteins; concomitantly, the lymph protein rose after Hespan resuscitation. This decrease in serum proteins and rise in lymph proteins parallels similar results after albumin resuscitation in man and animals and suggests that Hespan induces an oncotically controlled extravascular protein relocation. Further studies on the significance of these findings need to be conducted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451485      PMCID: PMC1493437          DOI: 10.1097/00000658-198804000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  12 in total

1.  Relocation of nonalbumin proteins after albumin resuscitation.

Authors:  R Denis; R W Smith; D Grabow; A M Ledgerwood; C E Lucas
Journal:  J Surg Res       Date:  1987-11       Impact factor: 2.192

2.  Experience with a thrombin clotting time assay for measuring heparin activity.

Authors:  J A Penner
Journal:  Am J Clin Pathol       Date:  1974-05       Impact factor: 2.493

3.  Plasma fibrinogen determination by automated thrombin time.

Authors:  T Okuno; V Selenko
Journal:  Am J Med Technol       Date:  1972-06

4.  Immunoglobulin changes after varied resuscitation regimens.

Authors:  D F Faillace; A M Ledgerwood; C E Lucas; K Kithier; R F Higgins
Journal:  J Trauma       Date:  1982-01

5.  Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock.

Authors:  C E Lucas; D L Bouwman; A M Ledgerwood; R Higgins
Journal:  J Trauma       Date:  1980-01

6.  Alterations in cellular membrane function during hemorrhagic shock in primates.

Authors:  G T Shires; J N Cunningham; C R Backer; S F Reeder; H Illner; I Y Wagner; J Maher
Journal:  Ann Surg       Date:  1972-09       Impact factor: 12.969

7.  Efficacy of hetastarch in the resuscitation of patients with multisystem trauma and shock.

Authors:  C H Shatney; K Deepika; P R Militello; T C Majerus; R B Dawson
Journal:  Arch Surg       Date:  1983-07

8.  Hemodynamic, blood volume, and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patients.

Authors:  S Lazrove; K Waxman; C Shippy; W C Shoemaker
Journal:  Crit Care Med       Date:  1980-05       Impact factor: 7.598

9.  Reduced oncotic pressure after shock: a proposed mechanism.

Authors:  C E Lucas; D J Benishek; A M Ledgerwood
Journal:  Arch Surg       Date:  1982-05

10.  Altered coagulation protein content after albumin resuscitation.

Authors:  C E Lucas; A M Ledgerwood; E F Mammen
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

View more
  5 in total

1.  Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.

Authors:  R Bach; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 2.  Adverse reactions to plasma volume expanders.

Authors:  M M Fisher; P W Brady
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

3.  Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial.

Authors:  K L Mattox; P A Maningas; E E Moore; J R Mateer; J A Marx; C Aprahamian; J M Burch; P E Pepe
Journal:  Ann Surg       Date:  1991-05       Impact factor: 12.969

Review 4.  Intravenous Fluid Administration and the Coagulation System.

Authors:  Corrin J Boyd; Benjamin M Brainard; Lisa Smart
Journal:  Front Vet Sci       Date:  2021-04-15

5.  Biomarkers of Coagulation and Inflammation in Dogs after Randomized Administration of 6% Hydroxyethyl Starch 130/0.4 or Hartmann's Solution.

Authors:  Corrin J Boyd; Anthea L Raisis; Claire R Sharp; Melissa A Claus; Giselle Hosgood; Lisa Smart
Journal:  Animals (Basel)       Date:  2022-10-06       Impact factor: 3.231

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.